Joseph Zack

Mr. Zack has been a C-level Life Sciences Executive for 20 years, spanning Biopharma to Diagnostics, from start-up to blue chip global companies. He has a strong track record of success in transforming/growing early stage and mid cap companies profitably through visionary/incisive leadership, innovation, and a broad operational skill set. He has built commercial organizations from “scratch”, took from inception to launch over a dozen products in his career (some of them blockbusters in their time, and most game changing/disruptive technologies), added to top and bottom line results with successful business development spanning Europe, Asia, Africa, and South America, and has played a significant role in capital formation. Mr. Zack’s particular domain expertise includes infectious disease, oncology, and endocrine diagnostics, regenerative medicine, wound healing, cardiovascular, neurology, and periodontal medicine. Mr. Zack’s most recent corporate role was as Senior Vice President Diagnostics at Metabolon. Other companies where he had senior leadership roles included OraSure Technologies, OraPharma, Advanced Tissue Sciences, and Ciba-Geigy (now Novartis). Currently Mr. Zack is the Principal of Zack Consulting Services, which advises early and midcap domestic and international companies, at the C-level, with business strategy, opportunity assessments, commercialization plans, product development, business development, and capital formation. Mr. Zack has a BA in Biology from Colgate University, and an MBA from St. John’s University.